BioCentury | Jun 4, 2012
Clinical News

XM-ONE: Postmarketing study started

...Allenex (formerly LinkMed AB) said Tulane University's Tulane Medical Center began an investigator-sponsored, prospective trial to...
BioCentury | Aug 29, 2011
Company News

Alden Impact Capital, Allenex transplant news

...Recopharma develops recombinant glycol-proteins for use in vaccine adjuvants and antimicrobials. Last year, Allenex (formerly LinkMed...
BioCentury | Jun 6, 2011
Company News

LinkMed finance news

...liquidity of these planned divestments with both short- and long-term measures. Details were not disclosed. LinkMed's...
...April, the company announced an investment shift to the transplant sector (see BioCentury, April 25). LinkMed...
BioCentury | May 30, 2011
Company News

LinkMed AB management update

...Departed: Founder Ingemar Lagerlof as CEO; he is succeeded by Anders Karlsson, formerly CEO of LinkMed's...
BioCentury | May 30, 2011
Company News

NorDiag, LinkMed AB deal

...NorDiag divested its 50% stake in Olerup International AB to LinkMed, increasing LinkMed's stake in Olerup...
...stake in Olerup International to 75% from 25%. Olerup International is a JV between NorDiag, LinkMed's...
...distribution of its Arrow product. Olerup International had 2010 revenues of SEK87.9 million ($13.1 million). LinkMed...
BioCentury | May 30, 2011
Company News

NorDiag, LinkMed AB deal

...NorDiag divested its 50% stake in Olerup International AB to LinkMed, increasing LinkMed's stake in Olerup...
...stake in Olerup International to 75% from 25%. Olerup International is a JV between NorDiag, LinkMed's...
...distribution of its Arrow product. Olerup International had 2010 revenues of SEK87.9 million ($13.1 million). LinkMed...
BioCentury | May 9, 2011
Company News

Conexio Genomics, LinkMed sales and marketing update

...Conexio granted LinkMed's Olerup SSP subsidiary an exclusive, five-year license to market Conexio's SBT Resolver- HLA...
...companies have also partnered to co-develop new HLA typing products. Conexio Genomics , Fremantle, Australia LinkMed...
BioCentury | Apr 25, 2011
Company News

LinkMed AB transplant news

...AB0 column is in development to remove antibodies for transplant (see BioCentury, Sept. 13, 2010). LinkMed...
BioCentury | Sep 13, 2010
Company News

LinkMed transplant news

...Private equity company LinkMed announced plans to shift its investment focus to the transplant sector. LinkMed...
...antibodies for transplant. The company will also acquire and in-license additional transplant-related companies and products. LinkMed...
...initial divestments from medical technology companies that have reached commercialization. Further details were not disclosed. LinkMed...
BioCentury | Nov 16, 2009
Company News

AbSorber AB, LinkMed AB deal

...Private equity company LinkMed will increase its holding in AbSorber to 93.8% from 43%. LinkMed will...
...in exchange for 492,043 new LinkMed shares valued at SEK13.9 million ($2 million) based on LinkMed's...
...prior to organ transplants. LinkMed said AbSorber's technologies complement those of Olerup SSP AB, which LinkMed...
Items per page:
1 - 10 of 13
BioCentury | Jun 4, 2012
Clinical News

XM-ONE: Postmarketing study started

...Allenex (formerly LinkMed AB) said Tulane University's Tulane Medical Center began an investigator-sponsored, prospective trial to...
BioCentury | Aug 29, 2011
Company News

Alden Impact Capital, Allenex transplant news

...Recopharma develops recombinant glycol-proteins for use in vaccine adjuvants and antimicrobials. Last year, Allenex (formerly LinkMed...
BioCentury | Jun 6, 2011
Company News

LinkMed finance news

...liquidity of these planned divestments with both short- and long-term measures. Details were not disclosed. LinkMed's...
...April, the company announced an investment shift to the transplant sector (see BioCentury, April 25). LinkMed...
BioCentury | May 30, 2011
Company News

LinkMed AB management update

...Departed: Founder Ingemar Lagerlof as CEO; he is succeeded by Anders Karlsson, formerly CEO of LinkMed's...
BioCentury | May 30, 2011
Company News

NorDiag, LinkMed AB deal

...NorDiag divested its 50% stake in Olerup International AB to LinkMed, increasing LinkMed's stake in Olerup...
...stake in Olerup International to 75% from 25%. Olerup International is a JV between NorDiag, LinkMed's...
...distribution of its Arrow product. Olerup International had 2010 revenues of SEK87.9 million ($13.1 million). LinkMed...
BioCentury | May 30, 2011
Company News

NorDiag, LinkMed AB deal

...NorDiag divested its 50% stake in Olerup International AB to LinkMed, increasing LinkMed's stake in Olerup...
...stake in Olerup International to 75% from 25%. Olerup International is a JV between NorDiag, LinkMed's...
...distribution of its Arrow product. Olerup International had 2010 revenues of SEK87.9 million ($13.1 million). LinkMed...
BioCentury | May 9, 2011
Company News

Conexio Genomics, LinkMed sales and marketing update

...Conexio granted LinkMed's Olerup SSP subsidiary an exclusive, five-year license to market Conexio's SBT Resolver- HLA...
...companies have also partnered to co-develop new HLA typing products. Conexio Genomics , Fremantle, Australia LinkMed...
BioCentury | Apr 25, 2011
Company News

LinkMed AB transplant news

...AB0 column is in development to remove antibodies for transplant (see BioCentury, Sept. 13, 2010). LinkMed...
BioCentury | Sep 13, 2010
Company News

LinkMed transplant news

...Private equity company LinkMed announced plans to shift its investment focus to the transplant sector. LinkMed...
...antibodies for transplant. The company will also acquire and in-license additional transplant-related companies and products. LinkMed...
...initial divestments from medical technology companies that have reached commercialization. Further details were not disclosed. LinkMed...
BioCentury | Nov 16, 2009
Company News

AbSorber AB, LinkMed AB deal

...Private equity company LinkMed will increase its holding in AbSorber to 93.8% from 43%. LinkMed will...
...in exchange for 492,043 new LinkMed shares valued at SEK13.9 million ($2 million) based on LinkMed's...
...prior to organ transplants. LinkMed said AbSorber's technologies complement those of Olerup SSP AB, which LinkMed...
Items per page:
1 - 10 of 13